Top

Clinical Research in Cardiology

Published in:

01-10-2015 | Letter to the Editors

Limitations in S-ICD therapy: reasons for system explantation

Authors: Gerrit Frommeyer, Dirk G. Dechering, Sven Zumhagen, Julia Köbe, Lars Eckardt, Florian Reinke

Published in: Clinical Research in Cardiology | Issue 10/2015

Excerpt

Sirs: …

Backhoff D, Muller M, Ruschewski W, Paul T, Krause U (2014) Icd therapy for primary prevention of sudden cardiac death after mustard repair for d-transposition of the great arteries. Clin Res Cardiol 103:894–901CrossRefPubMed

Kolb C, Lennerz C, Semmler V, Jilek C (2013) Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus. Clin Res Cardiol 102:169–170CrossRefPubMed

Yamazawa H, Takeda A, Takei K, Furukawa T (2014) Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging. Clin Res Cardiol 103:75–77CrossRefPubMed

Alcalde M, Campuzano O, Sarquella-Brugada G, Arbelo E, Allegue C, Partemi S, Iglesias A, Oliva A, Brugada J, Brugada R (2015) Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol 104:288–303CrossRefPubMed

Bobinger T, Kallmunzer B, Kopp M, Kurka N, Arnold M, Hilz MJ, Huttner HB, Schwab S, Kohrmann M (2015) Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: A prospective observational study. Clin Res Cardiol. doi:10.1007/s00392-015-0831-6

Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kaab S, Murgatroyd F, Reeve HL, Carter N, Boersma L (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the effortless S-ICD registry. Eur Heart J 35:1657–1665PubMedCentralCrossRefPubMed

Aziz S, Leon AR, El-Chami MF (2014) The subcutaneous defibrillator: a review of the literature. J Am Coll Cardiol 63:1473–1479CrossRefPubMed

Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 100:737–744PubMedCentralCrossRefPubMed

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60:1933–1939CrossRefPubMed

10.

Jarman JW, Todd DM (2013) United kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 15:1158–1165CrossRefPubMed

11.

Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128:944–953CrossRefPubMed

12.

Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. New Engl J Med 363:36–44CrossRefPubMed

13.

Porterfield C, DiMarco JP, Mason PK (2015) Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker. Am J Cardiol 115:276–278CrossRefPubMed

14.

Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V, Mahajan D, Sanghera R, Gold MR (2015) A new algorithm to reduce inappropriate therapy in the s-icd system. J Cardiovasc Electrophysiol 26:417–423CrossRefPubMed

15.

Aydin A, Hartel F, Schluter M, Butter C, Kobe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circulation Arrhythm Electrophysiol 5:913–919CrossRef

16.

Guenther M, Kolschmann S, Knaut M (2015) Substernal lead implantation: a novel option to manage DFT failure in S-ICD patients. Clin Res Cardiol 104:189–191CrossRefPubMed

Title: Limitations in S-ICD therapy: reasons for system explantation
Authors: Gerrit Frommeyer
Dirk G. Dechering
Sven Zumhagen
Julia Köbe
Lars Eckardt
Florian Reinke
Publication date: 01-10-2015
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 10/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-015-0880-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Limitations in S-ICD therapy: reasons for system explantation

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2015

Valve-in-valve Medtronic CoreValve implantation into a degenerated transapical Ventor Embracer aortic valve bioprosthesis

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial

Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry

Abnormal mitral–aortic intervalvular coupling in mitral valve diseases: a study using real-time three-dimensional transesophageal echocardiography

Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page